UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

British journal of pharmacology, 2019-05, Vol.176 (10), p.1455-1469

2019

Volltextzugriff (PDF)

Gene–environment interplay in the etiology of psychosis

Psychological medicine, 2018-09, Vol.48 (12), p.1925-1936

2018

Volltextzugriff (PDF)

Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro

Brain, behavior, and immunity, 2022-10, Vol.105, p.29-43

2022

Volltextzugriff (PDF)

The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation

Frontiers in pharmacology, 2022-02, Vol.12, p.806417-806417

2022

Volltextzugriff (PDF)

Neurodevelopmental and genetic determinants of exposure to adversity among youth at risk for mental illness

Journal of child psychology and psychiatry, 2020-05, Vol.61 (5), p.536-544

2020

Volltextzugriff (PDF)

Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin

Pharmacological research, 2024-11, Vol.209, p.107443, Article 107443

2024

Volltextzugriff (PDF)

The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma

Journal of neuroimmunology, 2022-11, Vol.372, p.577971-577971, Article 577971

2022

Volltextzugriff (PDF)

Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments

Journal of neuroscience research, 2020-12, Vol.98 (12), p.2496-2509

2020

Volltextzugriff (PDF)

Cannabinoid receptor ligand bias: implications in the central nervous system

Current opinion in pharmacology, 2017-02, Vol.32, p.32-43

2017

Volltextzugriff (PDF)

JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia

Journal of neuroimmune pharmacology, 2024-04, Vol.19 (1), p.14-14, Article 14

2024

Volltextzugriff (PDF)

Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease

Molecular pharmacology, 2016-03, Vol.89 (3), p.364-375

2016

Volltextzugriff (PDF)

Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons

The Journal of biological chemistry, 2014-09, Vol.289 (36), p.24845-24862

2014

Volltextzugriff (PDF)

Subfunctionalization of peroxisome proliferator response elements accounts for retention of duplicated fabp1 genes in zebrafish

BMC evolutionary biology, 2016-07, Vol.16 (1), p.147, Article 147

2016

Volltextzugriff (PDF)

Genetic counselling for the prevention of mental health consequences of cannabis use: A randomized controlled trial‐within‐cohort

Early intervention in psychiatry, 2021-10, Vol.15 (5), p.1306-1314

2021

Volltextzugriff (PDF)

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Neuropharmacology, 2019-06, Vol.151, p.1-12

2019

Volltextzugriff (PDF)

Differential regulation of the duplicated fabp7, fabp10 and fabp11 genes of zebrafish by peroxisome proliferator activated receptors

Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2017-11, Vol.213, p.81-90

2017

Volltextzugriff (PDF)

The impact of ovariectomy on calcium homeostasis and myofilament calcium sensitivity in the aging mouse heart

PloS one, 2013-09, Vol.8 (9), p.e74719-e74719

2013

Volltextzugriff (PDF)

Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers

European journal of pharmacology, 2017-10, Vol.813, p.66-83

2017

Volltextzugriff (PDF)

Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio)

BMC evolutionary biology, 2012-07, Vol.12 (1), p.112, Article 112

2012

Volltextzugriff (PDF)

Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2‑Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators

Journal of medicinal chemistry, 2020-01, Vol.63 (2), p.542-568

2020

Volltextzugriff (PDF)

Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: Implications for Huntington's disease

Neuropharmacology, 2013-09, Vol.72, p.47-57

2013

Volltextzugriff (PDF)

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice

Molecular therapy, 2005-10, Vol.12 (4), p.618-633

2005

Volltextzugriff (PDF)

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)

Journal of medicinal chemistry, 2016-01, Vol.59 (1), p.44-60

2016

Volltextzugriff (PDF)

Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1

Neurochemistry international, 2019-02, Vol.123, p.85-94

2019

Volltextzugriff (PDF)

Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies

Psychopharmacology, 2021-04, Vol.238 (4), p.1087-1098

2021

Volltextzugriff (PDF)

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(348)
Mit Volltextzugriff
(422)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(488)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Gene–environment interplay in the etiology of psychosis

Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro

The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation

Neurodevelopmental and genetic determinants of exposure to adversity among youth at risk for mental illness

Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin

The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma

Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments

Cannabinoid receptor ligand bias: implications in the central nervous system

JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia

Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease

Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons

Subfunctionalization of peroxisome proliferator response elements accounts for retention of duplicated fabp1 genes in zebrafish

Genetic counselling for the prevention of mental health consequences of cannabis use: A randomized controlled trial‐within‐cohort

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Differential regulation of the duplicated fabp7, fabp10 and fabp11 genes of zebrafish by peroxisome proliferator activated receptors

The impact of ovariectomy on calcium homeostasis and myofilament calcium sensitivity in the aging mouse heart

Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers

Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio)

Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2‑Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators

Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: Implications for Huntington's disease

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)

Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1

Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies

Suchergebnisse filtern